// App-Quantinova.ai

2823 : Identification of highly selective inhibitors of cyclin-dependent kinase 12

Researchers

Presenter

  • Axel Choidas

Principal Investigators

  • Carsten Schultz-Fademrecht

  • Carsten Degeenhardt

  • Peter Habenberger

  • Uwe Koch

  • Jan E. Eickhoff

  • Ann Kathrin Greifenberg

  • Peter Nussbaumer

  • Matthias Geyer

  • Bert M. Klebl

Medical Centers

  • Lead Discovery Center, Dortmund, Germany

  • Research Center Caesar & University of Bonn, Bonn, Germany.

Locations

  • Germany

Companies

  • Lead Discovery Cente

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • High grade serous ovarian cancer

  • Solid malignancies

Biomarkers

  • Cyclin dependent kinase 1

  • Cyclin dependent kinase 2

  • Cyclin dependent kinase 6

  • Cyclin dependent kinase 7

  • Cyclin-dependent kinase 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved